viewTHC Global Group Ltd

THC Global Group Ltd granted trading halt by ASX

THC Global operates under a ‘Farm to Pharma’ pharmaceutical model.

ASX through glass window
Shares in the company last traded at 42 cents before going into halt

THC Global Group Ltd (ASX:THC) has been granted a trading halt by the ASX pending the release of information regarding the grant of a manufacture licence by the Office of Drug Control.

Shares in the company will remain halted until the earlier of either, the release of relevant information, or, the commencement of trading next Tuesday 9 July 2019.

READ: THC Global has full suite of cannabis licences to advance farm-to-pharma model

THC is in a prime position to commence medicinal cannabis production to service both domestic patients and the global export market.

The company is active globally with operations in Australia, New Zealand, and Canada and partnerships across Europe, Asia, and the Middle East.

In addition to its core Australian medicinal cannabis assets, THC has a significant Canadian presence – both in cannabis and in hydroponics equipment.

Quick facts: THC Global Group Ltd

Price: 0.435 AUD

Market: ASX
Market Cap: $63.19 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...



THC Global granted manufacturing licence by Australian Office of Drug Control

THC Global Group Ltd (ASX:THC) chief executive officer Ken Charteris updates Proactive Investors on the manufacturing licence granted to the cannabis company by the Australian Office of Drug Control.   "It's a significnat milestone ... we now are a farm-to-pharma process which...

on 13/6/19

2 min read